Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Dextroamphetamine and Fenclonine

Research Papers that Mention the Interaction

The 5-hydroxytryptamine (5-HT) depleting agent p-chlorophenylalanine potentiated the effect of low doses of dexamphetamine but had no net effect on ED50 values; reserpine behaved similarly.
Psychopharmacology  •  2004  |  View Paper
Abstract P-chlorophenylalanine , an inhibitor of serotonin synthesis, was found to completely prevent the inhibitory effect of morphine and methadone on the stereotypy caused by d-amphetamine and methyl-phenidate in rats.
Life sciences  •  1981  |  View Paper
In contrast, pretreatment of WKY rats with parachlorophenylalanine resulted in an increase in rearing and a decrease in head waving following an injection of d-amphetamine.
Pharmacology Biochemistry and Behavior  •  1980  |  View Paper
The predominant effects produced by the low dose of D-amphetamine (0.5 mg/kg), i.e., enhanced crossovers and rearings, were found to be significantly elevated after PCPA administration.
Brain Research  •  1976  |  View Paper
However, in the frontal cortex, pCPA pretreatment augmented the amplitude of, and prolonged, the noradrenergic response to local infusion of d-amphetamine (10 microM).
In the hypothalamus, pCPA did not affect the amplitude of the response to either of these agents but did prolong the effects of d-amphetamine on noradrenaline efflux.
Neuropharmacology  •  2004  |  View Paper
Both 5-hydroxytryptamine (5-HT) ICV and p-chlorophenylalanine potentiated the effect of d-amphetamine.
Psychopharmacology  •  2004  |  View Paper
In contrast, the pronounced increase in firing rate produced by 7.5 mg/kg D-amphetamine in control rats was significantly reduced following PCPA pretreatment.
The differential effects of PCPA on the action of low and high doses of D-amphetamine in the anterior neostriatum may explain the differential influence of serotonergic systems on amphetamine-induced locomotion add stereotypy.
Brain Research  •  1981  |  View Paper
PCPA pretreatment potentiated the increased accumulation of striatal [3H]dopamine (DA) induced by doses of AMPH to 1.5 mg/kg, and inhibited the decrease in striatal [3H]DA accumulation observed at higher doses (greater than 2.5 mg/kg) of AMPH.
Brain Research  •  1979  |  View Paper
Locomotor activity induced by d-amphetamine was found to be potentiated by food deprivation, a tryptophan-free diet, p-chlorophenylalanine and drugs proposed to antagonize serotonin receptors in brain.
The Journal of pharmacology and experimental therapeutics  •  1976  |  View Paper
Previous studies have reported that rats given either midbrain raphe lesions or the serotonin synthesis inhibitor, p-chlorophenylalanine , show an increase above controls in their locomotor response to various doses of (+)-amphetamine.
Neuropharmacology  •  1975  |  View Paper